Longitudinal Study of Biomarkers
A Longitudinal Study of Biomarkers in Pediatric Patients With Central Nervous System Tumors
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Listed as NCT01595126, this observational or N/A phase trial focuses on Central Nervous System Tumor and remains completed. Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, it has been updated 8 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
8 versions recorded-
Mar 2025 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Mar 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ann & Robert H Lurie Children's Hospital of Chicago
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Chicago, United States